Products
Companies
News
About
About
Add your product
Contact
Newsletter
×
Subscribe to our monthly newsletter
Subscribe
Products
InferRead DR Tuberculosis
InferRead DR Tuberculosis
Infervision
Information source:
Public
Last updated:
Sept. 1, 2021
General Information
Technical Specifications
Regulatory
Market
Evidence
General Information
General
Product name
InferRead DR Tuberculosis
Company
Infervision
Subspeciality
Chest
Modality
X-ray
Disease targeted
Tuberculosis
Key-features
Tuberculosis detection
Suggested use
Technical Specifications
Data characteristics
Population
Input
Input format
Output
Output format
Technology
Integration
Deployment
Trigger for analysis
Processing time
Regulatory
Certification
CE
Certified, Class IIa
, MDD
FDA
No or not yet
Intended Use Statements
Intended use (according to CE)
The design, Development and Manufacture of Computer aided diagnostic software for viewing and analyzing DICOM images to assist physicians with abnormality detection and diagnosis.
Market
Market presence
On market since
01-2020
Distribution channels
Stop TB Partnership Global Drug Facility
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Based on
Evidence
Evidence
Peer reviewed papers on performance
Tuberculosis detection from chest x-rays for triaging in a high tuberculosis-burden setting: an evaluation of five artificial intelligence algorithms
(read)
Non-peer reviewed papers on performance
Other relevant papers